SCHEMBL1408501

SCHEMBL1408501

O=C1C(c2ccccc2)=Cc2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.64
PTPN1 P18031 4/20 0.53
PTPRC P08575 4/20 0.53
CDC25B P30305 3/20 0.53
PTPRF P10586 1/20 0.53
CDC25A P30304 1/20 0.46
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 3/20 0.43
THRB P10828 3/20 0.43
KDM4E B2RXH2 2/20 0.43
BCHE P06276 2/20 0.43
POLB P06746 2/20 0.43
CES1 P23141 2/20 0.43
RECQL P46063 2/20 0.43
ALDH1A1 P00352 1/20 0.43
PKM P14618 1/20 0.43
IDO1 P14902 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28277167 0.94 BACE1 (0.57) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL29809142 0.94 BACE1 (0.57) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL3444897 0.86 CDC25B (0.57) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL8240772 0.86 BACE1 (0.48) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL3713042 0.83 MAPK1 (0.61) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL13475649 0.83 BACE1 (0.46) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL31682254 0.83 MAPK1 (0.61) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL7119051 0.82 CDC25B (0.53) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL9120460 0.81 PTPN1 (0.50) BACE1PTPN1PTPRCCDC25BPTPRF
SCHEMBL978806 0.80 BACE1 (0.48) BACE1PTPN1PTPRCCDC25BPTPRF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116143602-B Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof 西南大学 2024-10-22 CN disclosed
CN-116554104-A Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof 西南大学 2023-08-08 CN disclosed
CN-116143602-A Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof 西南大学 2023-05-23 CN disclosed
US-20200392259-A1 ORTHOMETALLATED CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION AND COPOLYMERIZATION ARZOUMANIDIS GREGORY G (US) 2020-12-17 US disclosed
US-20200207982-A1 POLYAMIDE BLENDS DOW SILICONES CORP (US) 2020-07-02 US disclosed
EP-3655482-A1 POLYAMIDE BLENDS Dow Silicones Corporation (US) 2020-05-27 EP disclosed
WO-2019018094-A1 POLYAMIDE BLENDS DOW SILICONES CORPORATION (US) 2019-01-24 WO disclosed
EP-2294101-B1 POLYMERS MODIFIED BY SILANES DOW SILICONES CORP (US) 2018-10-17 EP disclosed
EP-2521752-B1 ORGANOPOLYSILOXANES CONTAINING AN UNSATURATED GROUP DOW CORNING (US) 2017-10-25 EP disclosed
US-9493615-B2 Organopolysiloxanes containing an unsaturated group DOW CORNING CORPORATION (US) 2016-11-15 US disclosed
WO-2010000478-A1 MODIFIED POLYOLEFINS DOW CORNING CORPORATION (US) 2010-01-07 WO disclosed
US-6790998-B2 SUCH AS 5-METHYL-3-PHENYL)-INDEN-1-ONE FOR ENANTIOSELECTIVE PREPARATION OF TOLTERODINE AND ANALOGUES/SALTS THEREOF PHARMACIA AB (SE) 2004-09-14 US disclosed
EP-0776913-B1 High molecular weight copolymers BASELL POLYOLEFINE GMBH (DE) 2004-02-04 EP disclosed
US-20030191348-A1 Such as 5-methyl-3-phenyl)-inden-1-one for enantioselective preparation of tolterodine and analogues/salts thereof ANDERSSON PHER G (SE) 2003-10-09 US disclosed
EP-1270614-A2 Copolymers containing propylene and alpha-olefin comonomer Basell Polyolefine GmbH (DE) 2003-01-02 EP disclosed
EP-0790076-B1 Catalysts containing metallocenes with arylsubstituted indenyl derivatives as ligands, process and intermediates for the preparation of these metallocenes and their use BASELL POLYOLEFINE GMBH (DE) 2001-12-05 EP disclosed
EP-0576970-B1 Metallocenes with arylsubstituted indenyl-derivatives as ligands, process for their preparation and their use as catalysts HOECHST AG (DE) 1998-01-14 EP disclosed
EP-0790076-A2 Catalysts containing metallocenes with arylsubstituted indenyl derivatives as ligands, process and intermediates for the preparation of these metallocenes and their use HOECHST AKTIENGESELLSCHAFT (DE) 1997-08-20 EP disclosed
EP-0776913-A2 High molecular weight copolymers HOECHST AKTIENGESELLSCHAFT (DE) 1997-06-04 EP disclosed
EP-0576970-A1 Metallocenes with arylsubstituted indenyl-derivatives as ligands, process for their preparation and their use as catalysts HOECHST AKTIENGESELLSCHAFT (DE) 1994-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191348-A1 Such as 5-methyl-3-phenyl)-inden-1-one for enantioselective preparation of tolterodine and analogues/salts thereof CYP1B1, CYP4B1, THRB BACE1 2921/4885PTPN1 3330/4885PTPRC 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.